Question:
CASE 1
A previously well 17 year-old male involved in a motor-vehicle accident sustained multiple injuries including left acetabular and displaced comminuted pelvic fractures, both requiring surgical fixation. Pudendal artery damage resulted in a left retroperitoneal, extraperitoneal, and preperitoneal hematoma. He received intensive supportive care, including empiric intravenous amoxicillin-clavulanate, a central venous catheter, and a urinary catheter.
On day 8, fevers developed and piperacillin-tazobactam and vancomycin were commenced. A computerized tomography (CT) scan of the chest, abdomen, and pelvis did not reveal an infective source. Fevers persisted, and he developed increasing left hip pain. A repeat CT scan on day 13 revealed a new collection around the left lateral pelvic wall, contiguous with the pelvic fixation and left hip joint (Figure 1). On day 16, an ultrasound guided aspirate of the pelvic collection was performed, and he underwent pelvic washout and debridement.
Figure 1.
Case 1: CT abdomen and pelvic portal venous phase intravenous contrast enhanced CT scan. A, Coronal plane image with arrows pointing to fluid collections. B, Sagittal plane image with arrows pointing to fluid collections.
The pelvic aspirate had 37 000 leucocytes (40 × phase contrast). No organisms were seen on Gram stain. At day 2 of incubation on horse blood agar (HBA) (Thermofisher, Waltham, Massachusetts, USA) in anaerobic conditions at 35°C, tiny translucent colonies had grown (Figure 3A), which were identified using matrix-assisted laser desorption ionization time-of-flight mass-spectrometry (MALDI-TOF MS). A color change occurred with subculture onto specialized agar (Figure 3B). Examination under direct microscopy revealed 2 organisms with distinct colony morphologies (Figure 3C).
Figure 3.
A, Tiny translucent white colonies on horse blood agar (Thermofisher, Waltham, USA) at 48 hours of incubation in anaerobic conditions at 35°C. B, Color change of A8 agar (Media Preparation Unit, University of Melbourne, Parkville, Australia) resulting from urease production in the presence of the CaCl2 indicator contained in the medium. C, Fluid from left pelvic collection. Colony morphologies identified on A8 agar after 48 hours of anaerobic incubation and viewed with a stereomicroscope (x40 magnification). Red arrows indicating an organism with a dense center and paler outer zone. Blue arrows indicating an organism with a brown granular appearance.
CASE 2
Several months later, a previously well 17 year-old woman involved in a motor-vehicle accident sustained injuries including a shattered right kidney with a large perinephric hematoma requiring a nephrouretectomy; a left ureteric transection requiring anastomosis and stenting; and D3/4 duodenal tear managed with resection via laparotomy. Intraoperatively, a large volume retroperitoneal urinoma was drained. She commenced empiric piperacillin-tazobactam.
Retroperitoneal fluid microscopy and Gram stain were unrevealing. Culture was negative for growth. After 8 days of piperacillin-tazobactam, she developed further fevers and rising inflammatory markers. Meropenem was commenced. A CT intravenous pyelogram (Figure 2) revealed ongoing urinary leak. Abdominal and pelvic CT revealed a complex collection.
Figure 2.
Case 2: CT abdomen and pelvis (intravenous pyelogram). A, Coronal plane image with arrows pointing to fluid collections. B, Sagittal plane image with red arrows pointing towards fluid collection and blue arrow pointing towards contrast leakage in the left perinephric space indicating left renal urinary leak from the pelviureteric junction.
This abdominal fluid was drained. After 4 days of incubation on HBA plates in anaerobic conditions at 35°C, tiny translucent colonies were revealed, identified using MALDI-TOF MS and confirmed with real-time polymerase chain reaction using the Anylpex II STI-7 assay (Seegene, Seoul, South Korea). After 2 days of subculture onto specialized agar, direct microscopy revealed 2 organisms with distinct colony morphologies identical to Case 1 (Figure 3C).
What is the diagnosis?
Answer:
Mycoplasma hominis and Ureaplasma species infections.
Case 1 had a Mycoplasma hominis and Ureaplasma urealyticum pelvic collection and metalware infection, and left hip septic arthritis (culture and polymerase chain reaction [PCR] positive). We propose that instrumentation of the genitourinary tract with a urinary catheter led to hematogenous metastatic seeding of these organisms. He was managed with doxycycline and ciprofloxacin, and his fevers subsided and pain improved.
Case 2 had a M. hominis and Ureaplasma species retroperitoneal urinoma likely secondary to the ongoing urinary leak. The patient was commenced on doxycycline and demonstrated clinical improvement.
DISCUSSION
Mycoplasma hominis and Ureaplasma spp. belong to the Mollicutes class of bacteria. They lack a cell wall and therefore are unable to be visualized by Gram stain. They are normal commensal genitourinary tract flora in sexually active adults and can disseminate to other sites following mucosal disruption [1–6], most commonly in immunocompromised patients, particularly secondary to congenital immune defects, and also hematological malignancy and solid organ transplant [7–9].
The detection of Mollicutes in clinical specimens is challenging. It should be considered when initial microbiological testing (eg, Gram stain, routine culture) is unrevealing or if the patient does not improve on empiric antimicrobial therapy for more common pathogens [1, 10]. If these organisms are suspected, the specimen should be inoculated into broth culture media, sub-cultured onto A8 agar, and incubated for at least 48 hours under anaerobic conditions, both forming tiny pinpoint colonies. When viewed under a stereomicroscope, M. hominis colonies have a “fried egg” appearance with a denser center and paler outer zone, whereas Ureaplasma spp. colonies have a brown granular appearance. These miscroscopic findings are pathognomonic for these organisms without any legitimate differential diagnoses [8, 11]. Nucleic acid amplification tests (eg, PCR assay) can expedite pathogen identification [8, 12–14].
Mollicute septic arthritis is rare [1, 8]. Although M. hominis or Ureaplasma spp. single organism septic arthritis and periprosthetic joint infections have been reported in immunocompromised hosts [7, 15–21], there are very few case reports involving immunocompetent patients [5, 15, 20, 22–27]. To our knowledge, there is only 1 previous case of dual infection with M. hominis and U. parvum septic arthritis in an immunocompromised patient [28]. To the best of our knowledge, Case 1 is the first case of an immunocompetent patient developing dual Molliculite septic arthritis with metalware infection.
There are few cases of dual Mycoplasma and Ureaplasma non-genitourinary infection. In addition to Haller et al (1991) above [28], other authors have described dual infections in patients who underwent liver transplantation complicated by colonic perforation managed with ciprofloxacin; coronary artery bypass surgery with sternal wound infection treated with intravenous clindamycin and doxycycline, then oral doxycycline [29]; and mediastinitis, pleuritis, and pericarditis following cardiothoracic surgery in an immunocompromised patient, managed with doxycycline and clindamycin but succumbed to disseminated infection [30].
Understanding optimal antimicrobial selection is limited by lack of standardized methods and clinical breakpoints for antimicrobial susceptibility testing. Additionally, clinical data on the treatment of these organisms are limited to case reports and series, with limited data on clinical or microbiological response [1, 31–34]. Beta-lactam antibiotics and vancomycin are inactive because they target the cell wall. Myoplasma and Ureaplasma spp. are generally susceptible to agents that inhibit protein synthesis [35]. Fluoroquinolones, which are bactericidal against mycoplasmas should be considered for empiric treatment. Doxycycline should also be considered, although resistance may be increasing [1]. It is reasonable to use combination therapy (eg, moxifloxacin and doxycycline) [1, 34].
CONCLUSION
Mollicutes should be considered as a cause of infection in patients sustaining disruption to genitourinary tract mucosa, or where there has been difficulty in isolating an organism or inadequate response to empiric antibiotics of more common organisms. There are limitations of susceptibility testing of these organisms. Empiric treatment of non-genital infections with fluroquinolones and tetracyclines should be considered.
Contributor Information
Kim Yeoh, Department of Microbiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity . Melbourne, Victoria, Australia.
Dilare Aikeremu, Department of Microbiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Benjamin Aw-Yeong, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Monica A Slavin, Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity . Melbourne, Victoria, Australia; Department of Infectious Diseases, and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Eloise Williams, Department of Microbiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity . Melbourne, Victoria, Australia.
Notes
Financial support. There were no sources of funding for this paper.
References
- 1. Waites K. Mycoplasma hominis and Ureaplasma infections. In: Waltham WA, ed. Uptodate. Available at: https://www.uptodate.com/contents/mycoplasma-hominis-and-ureaplasma-infections?search=ureaplasma&source=search_result&selectedTitle=1∼31&usage_type=default&display_rank=1. Accessed 4 December 2021.
- 2. McCormack WM, Lee YH, Zinner SH. Sexual experience and urethral colonization with genital mycoplasmas. A study in normal men. Ann Intern Med 1973; 78:696–8. [DOI] [PubMed] [Google Scholar]
- 3. McCormack WM, Almeida PC, Bailey PE, Grady EM, Lee YH. Sexual activity and vaginal colonization with genital mycoplasmas. JAMA 1972; 221:1375–7. [PubMed] [Google Scholar]
- 4. Cassell GH, Cole BC. Mycoplasmas as agents of human disease. N Engl J Med 1981; 304:80–9. [DOI] [PubMed] [Google Scholar]
- 5. McMahon DK, Dummer JS, Pasculle AW, Cassell G. Extragenital Mycoplasma hominis infections in adults. Am J Med 1990; 89:275–81. [DOI] [PubMed] [Google Scholar]
- 6. Leli C, Mencacci A, Latino MA, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect 2018; 51:220–5. [DOI] [PubMed] [Google Scholar]
- 7. George MD, Cardenas AM, Birnbaum BK, Gluckman SJ. Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis. J Clin Rheumatol 2015; 21:221–4. [DOI] [PubMed] [Google Scholar]
- 8. Chen Y, Huang Z, Fang X, Li W, Yang B, Zhang W. Diagnosis and treatment of mycoplasmal septic arthritis: a systematic review. Int Orthop 2020; 44:199–213. [DOI] [PubMed] [Google Scholar]
- 9. Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis 1993; 17:S243–9. [DOI] [PubMed] [Google Scholar]
- 10. Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 1996; 23:671–82. quiz 83–4. [DOI] [PubMed] [Google Scholar]
- 11. Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Pfaller MCK, ed., Manual of clinical microbiology. Washington DC: ASM Press, 2015:1082–7. [Google Scholar]
- 12. Waites KB, Xiao L, Paralanov V, Viscardi RM, Glass JI. Molecular methods for the detection of Mycoplasma and Ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14:437–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. van Doornum GJ, Schutten M, Voermans J, Guldemeester GJ, Niesters HG. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J Med Virol 2007; 79:1868–76. [DOI] [PubMed] [Google Scholar]
- 14. Loens K, Ieven M. Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics. Front Microbiol 2016; 7:448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Luttrell LM, Kanj SS, Corey GR, et al. Mycoplasma hominis septic arthritis: two case reports and review. Clin Infect Dis 1994; 19:1067–70. [DOI] [PubMed] [Google Scholar]
- 16. Mechai F, Le Moal G, Duchene S, Burucoa C, Godet C, Freslon M. Mycoplasma hominis osteitis in an immunocompetent man. Eur J Clin Microbiol Infect Dis 2006; 25:715–7. [DOI] [PubMed] [Google Scholar]
- 17. Roerdink RL, Douw CM, Leenders AC, et al. Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient. Infection 2016; 44:807–10. [DOI] [PubMed] [Google Scholar]
- 18. Qiu HJ, Lu WP, Li M, et al. The infection of Mycoplasma hominis after total knee replacement: case report and literature review. Chin J Traumatol 2017; 20:243–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Xiang L, Lu B. Infection due to Mycoplasma hominis after left hip replacement: case report and literature review. BMC Infect Dis 2019; 19:50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Skoldenberg OG, Rysinska AD, Neander G, Muren OH, Ahl TE. Ureaplasma urealyticum infection in total hip arthroplasty leading to revision. J Arthroplasty 2010; 25:1170 e11–3. [DOI] [PubMed] [Google Scholar]
- 21. Sneller M, Wellborne F, Barile MF, Plotz P. Prosthetic joint infection with Mycoplasma hominis. J Infect Dis 1986; 153:174–5. [DOI] [PubMed] [Google Scholar]
- 22. Sethi S, Sharma M, Gill SS. Septic arthritis due to Ureaplasma urealyticum. Indian Pediatr 2000; 37:552–4. [PubMed] [Google Scholar]
- 23. Vittecoq O, Schaeverbeke T, Favre S, et al. Molecular diagnosis of Ureaplasma urealyticum in an immunocompetent patient with destructive reactive polyarthritis. Arthritis Rheum 1997; 40:2084–9. [DOI] [PubMed] [Google Scholar]
- 24. Verinder DG. Septic arthritis due to Mycoplasma hominis: a case report and review of the literature. J Bone Joint Surg Br 1978; 60-B:224. [DOI] [PubMed] [Google Scholar]
- 25. Kim SK. Mycoplasma hominis septic arthritis. Ann Plast Surg 1988; 20:163–6. [DOI] [PubMed] [Google Scholar]
- 26. Chew R, Woods ML. Decompressive laminectomy complicated by postoperative Mycoplasma hominis epidural abscess and meningitis in a young woman: a case report. JBJS Case Connect 2016; 6:e25. [DOI] [PubMed] [Google Scholar]
- 27. Young H, Henao-Martinez AF, Miller A, Wilson M, Price CS. Cluster or coincidence? An unusual cause of surgical site infections in adult trauma patients. Am J Infect Control 2012; 40:e265–7. [DOI] [PubMed] [Google Scholar]
- 28. MacKenzie CR, Nischik N, Kram R, Krauspe R, Jager M, Henrich B. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis 2010; 14:e307–9. [DOI] [PubMed] [Google Scholar]
- 29. Pigrau C, Almirante B, Gasser I, Pahissa A. Sternotomy infection due to Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1995; 14:597–8. [DOI] [PubMed] [Google Scholar]
- 30. Garcia-de-la-Fuente C, Minambres E, Ugalde E, Saez A, Martinez-Martinez L, Farinas MC. Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. J Med Microbiol 2008; 57:656–7. [DOI] [PubMed] [Google Scholar]
- 31. Geissdorfer W, Sandner G, John S, Gessner A, Schoerner C, Schroppel K. Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol 2008; 46:1141–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Eilers E, Moter A, Bollmann R, Haffner D, Querfeld U. Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney. J Clin Microbiol 2007; 45:1066–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Gerber L, Gaspert A, Braghetti A, et al. Ureaplasma and Mycoplasma in kidney allograft recipients—a case series and review of the literature. Transpl Infect Dis 2018; 20:e12937. [DOI] [PubMed] [Google Scholar]
- 34. Waites KB, Duffy LB, Bebear CM, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol 2012; 50:3542–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. De Francesco MA, Caracciolo S, Bonfanti C, Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother 2013; 19:621–7. [DOI] [PubMed] [Google Scholar]



